Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
XTLB XTL Biopharmaceuticals Ltd American Depositary Shares rises 42 percent following release of its 2025 first quarter earnings report Red River RRBI Stock Extra Dividend Institutional Selling 20260416 BLK BlackRock Inc delivers 75 percent Q1 2026 EPS upside lifting shares 265 percent higher in todays trading VTOL Bristow Group Inc posts a 317 percent Q4 2025 EPS miss versus estimates with shares edging lower today Relay Therapeutics RLAY Stock Stability Assessment Buying Pressure 20260418 What signals matter most for First FNWB stock Momentum Building 20260418 CACC Credit Acceptance Corporation Q4 2025 earnings miss estimates shares edge lower despite 72 percent year over year revenue growth Skyworks Solutions Inc SWKS Semiconductor Analyst Coverage and Outlook Amid Mixed Q2 Results Is Karyopharm Therapeutics KPTI stock considered a safe play Q4 2025 Below Expectations Is Enerflex EFXT stock weak today Institutional Selling 20260418 Is Mitsubishi MUFG stock heading higher Q1 2026 EPS Beats Forecasts COSM Cosmos Health shares gain 355 percent despite steep Q4 2025 earnings per share miss CRGY Crescent posts 534 percent Q1 2026 EPS beat shares rise modestly after earnings announcement UCB United reports narrow Q1 2026 EPS miss shares drop 146 in todays trading session How Dingdong DDL margins compare to industry leaders 078 20260506 How Comcast Corporation CMCSA performance compares to expectations Slow Drop 20260508 What Celestica CLS is doing to stay ahead Flirts with Support 20260506 CBRE Group Q1 2026 earnings crush estimates with 398 EPS beat revenue rises 134 to 4055B iShares MSCI Canada ETF EWC Temporary US Tariff Exemption Eases NearTerm Pressure But USMCA Review Poses Persistent Downside Risks What equalweight Bullfrog AI BFRG Breakdown Watch 20260427 SBXE SilverBox management outlines key strategic growth priorities in its latest quarterly earnings report APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report